422 related articles for article (PubMed ID: 26280668)
1. Hepatitis B: 50 years after the discovery of Australia antigen.
Lok AS
J Viral Hepat; 2016 Jan; 23(1):5-14. PubMed ID: 26280668
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis B vaccines: protective efficacy and therapeutic potential.
Michel ML; Tiollais P
Pathol Biol (Paris); 2010 Aug; 58(4):288-95. PubMed ID: 20382485
[TBL] [Abstract][Full Text] [Related]
3. Prevention of hepatocellular carcinoma in hepatitis B virus infection.
Lim SG; Mohammed R; Yuen MF; Kao JH
J Gastroenterol Hepatol; 2009 Aug; 24(8):1352-7. PubMed ID: 19702903
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis B: review of development from the discovery of the "Australia Antigen" to end of the twentieth Century.
Yap SF
Malays J Pathol; 2004 Jun; 26(1):1-12. PubMed ID: 16190102
[TBL] [Abstract][Full Text] [Related]
5. Prevention of hepatitis B virus-associated liver diseases by antiviral therapy.
Tawada A; Kanda T; Imazeki F; Yokosuka O
Hepatol Int; 2016 Jul; 10(4):574-93. PubMed ID: 27026375
[TBL] [Abstract][Full Text] [Related]
6. Does antiviral therapy for hepatitis B and C prevent hepatocellular carcinoma?
Lok AS
J Gastroenterol Hepatol; 2011 Feb; 26(2):221-7. PubMed ID: 21070361
[TBL] [Abstract][Full Text] [Related]
7. Taiwan consensus statement on the management of chronic hepatitis B.
Chien RN; Kao JH; Peng CY; Chen CH; Liu CJ; Huang YH; Hu TH; Yang HI; Lu SN; Ni YH; Chuang WL; Lee CM; Wu JC; Chen PJ; Liaw YF
J Formos Med Assoc; 2019 Jan; 118(1 Pt 1):7-38. PubMed ID: 30527436
[TBL] [Abstract][Full Text] [Related]
8. Management of chronic hepatitis B infection.
Sundaram V; Kowdley K
BMJ; 2015 Oct; 351():h4263. PubMed ID: 26491030
[TBL] [Abstract][Full Text] [Related]
9. Breaking Hepatitis B Virus Tolerance and Inducing Protective Immunity Based on Mimicking T Cell-Independent Antigen.
Li X; Ni R
Viral Immunol; 2016 Nov; 29(9):502-509. PubMed ID: 27662269
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis B Virus (HBV) Core-Related Antigen During Nucleos(t)ide Analog Therapy Is Related to Intra-hepatic HBV Replication and Development of Hepatocellular Carcinoma.
Honda M; Shirasaki T; Terashima T; Kawaguchi K; Nakamura M; Oishi N; Wang X; Shimakami T; Okada H; Arai K; Yamashita T; Sakai Y; Yamashita T; Mizukoshi E; Kaneko S
J Infect Dis; 2016 Apr; 213(7):1096-106. PubMed ID: 26621908
[TBL] [Abstract][Full Text] [Related]
11. Clinical utility of HBV surface antigen quantification in HBV e antigen-negative chronic HBV infection.
Liaw YF
Nat Rev Gastroenterol Hepatol; 2019 Oct; 16(10):631-641. PubMed ID: 31477873
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis B Virus-Associated Hepatocellular Carcinoma.
Xie Y
Adv Exp Med Biol; 2017; 1018():11-21. PubMed ID: 29052129
[TBL] [Abstract][Full Text] [Related]
13. Global perspective on the natural history of chronic hepatitis B: role of hepatitis B virus genotypes A to J.
Liu CJ; Kao JH
Semin Liver Dis; 2013 May; 33(2):97-102. PubMed ID: 23749665
[TBL] [Abstract][Full Text] [Related]
14. Long-term follow-up of children with postnatal immunoprophylaxis failure who were infected with hepatitis B virus surface antigen gene mutant.
Hsu HY; Chang MH; Ni YH; Jeng YM; Chiang CL; Chen HL; Wu JF; Chen PJ
J Infect Dis; 2013 Apr; 207(7):1047-57. PubMed ID: 23300165
[TBL] [Abstract][Full Text] [Related]
15. [China's hepatitis B burden and expectation on 40 years of trials and tribulations].
Cai DC; Ren H
Zhonghua Gan Zang Bing Za Zhi; 2019 Jan; 27(1):3-5. PubMed ID: 30685915
[TBL] [Abstract][Full Text] [Related]
16. The clinical implications of hepatitis B virus genotype: Recent advances.
Lin CL; Kao JH
J Gastroenterol Hepatol; 2011 Jan; 26 Suppl 1():123-30. PubMed ID: 21199523
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis B vaccination in children: the Taiwan experience.
Ni YH; Chen DS
Pathol Biol (Paris); 2010 Aug; 58(4):296-300. PubMed ID: 20116181
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis B virus: from diagnosis to treatment.
Dény P; Zoulim F
Pathol Biol (Paris); 2010 Aug; 58(4):245-53. PubMed ID: 20580167
[TBL] [Abstract][Full Text] [Related]
19. Antiviral therapy for hepatitis B-related liver cancer prevention is more cost-effective than cancer screening.
Robotin MC; Kansil M; Howard K; George J; Tipper S; Dore GJ; Levy M; Penman AG
J Hepatol; 2009 May; 50(5):990-8. PubMed ID: 19303657
[TBL] [Abstract][Full Text] [Related]
20. The direct and indirect roles of HBV in liver cancer: prospective markers for HCC screening and potential therapeutic targets.
Ringelhan M; O'Connor T; Protzer U; Heikenwalder M
J Pathol; 2015 Jan; 235(2):355-67. PubMed ID: 25196558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
